These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9330125)

  • 1. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.
    Cohn JN; Fowler MB; Bristow MR; Colucci WS; Gilbert EM; Kinhal V; Krueger SK; Lejemtel T; Narahara KA; Packer M; Young ST; Holcslaw TL; Lukas MA
    J Card Fail; 1997 Sep; 3(3):173-9. PubMed ID: 9330125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.
    Packer M; Colucci WS; Sackner-Bernstein JD; Liang CS; Goldscher DA; Freeman I; Kukin ML; Kinhal V; Udelson JE; Klapholz M; Gottlieb SS; Pearle D; Cody RJ; Gregory JJ; Kantrowitz NE; LeJemtel TH; Young ST; Lukas MA; Shusterman NH
    Circulation; 1996 Dec; 94(11):2793-9. PubMed ID: 8941104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
    J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
    Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
    Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
    Metra M; Nardi M; Giubbini R; Dei Cas L
    J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
    Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
    Colucci WS; Packer M; Bristow MR; Gilbert EM; Cohn JN; Fowler MB; Krueger SK; Hershberger R; Uretsky BF; Bowers JA; Sackner-Bernstein JD; Young ST; Holcslaw TL; Lukas MA
    Circulation; 1996 Dec; 94(11):2800-6. PubMed ID: 8941105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure.
    Krum H; Gu A; Wilshire-Clement M; Sackner-Bernstein J; Goldsmith R; Medina N; Yushak M; Miller M; Packer M
    Am Heart J; 1996 Feb; 131(2):337-41. PubMed ID: 8579030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
    Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
    J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group.
    Krum H; Shusterman N; MacMahon S; Sharpe N
    J Card Fail; 1998 Dec; 4(4):281-8. PubMed ID: 9924849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.
    Krum H; Roecker EB; Mohacsi P; Rouleau JL; Tendera M; Coats AJ; Katus HA; Fowler MB; Packer M;
    JAMA; 2003 Feb; 289(6):712-8. PubMed ID: 12585949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.
    Cleland JG; Pennell DJ; Ray SG; Coats AJ; Macfarlane PW; Murray GD; Mule JD; Vered Z; Lahiri A;
    Lancet; 2003 Jul; 362(9377):14-21. PubMed ID: 12853194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.